Rossari Biotech Ltd (NSE:ROSSARI) Q2 FY23 Earnings Concall dated Nov. 07, 2022 Corporate Participants: Anoop Poojari -- Client Manager Edward Menezes --
Rossari Biotech Ltd (ROSSARI) Q2 FY23 Earnings Concall Transcript
Categories
Health Care
Tarsons Products Limited (TARSONS) Q2 FY23 Earnings Concall Transcript
Tarsons Products Limited (NSE:TARSONS) Q2 FY23 Earnings Concall dated Nov. 07, 2022 Corporate Participants: Rohan Sehgal -- Whole Time Director Santosh Agarwal --
Cipla Limited (CIPLA) Q2 FY23 Earnings Concall Transcript
Cipla Limited (NSE: CIPLA) Q2 FY23 Earnings Concall dated Nov. 04, 2022 Corporate Participants: Naveen Bansal -- Head of Investor Relations Ashish Adukia -- Global Chief
Hester Biosciences Limited (HESTERBIO) Q2 FY23 Earnings Concall Transcript
Hester Biosciences Limited (NSE:HESTERBIO) Q2 FY23 Earnings Concall dated Nov. 04, 2022 Corporate Participants: Rajiv Gandhi -- Chief Executive Officer and Managing Director
Sun Pharmaceutical Industries Limited Q2 FY23 Earnings Conference Call Insights
Key highlights from Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:46] Tushar Manudhane of Motilal Oswal asked about
Max Healthcare Institute Ltd (MAXHEALTH) Q2 FY23 Earnings Concall Transcript
Max Healthcare Institute Ltd (NSE:MAXHEALTH) Q2 FY23 Earnings Concall dated Nov. 02, 2022 Corporate Participants: Suraj Digawalekar -- CDR India Investor Relations
Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY23 Earnings Concall Transcript
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Q2 FY23 Earnings Concall dated Nov. 01, 2022 Corporate Participants: Nimish Desai -- Investor Relations Dilip S.
Glenmark Life Sciences Limited Q2 FY23 Earnings Conference Call Insights
https://youtu.be/FHgUfHa30gw Key highlights from Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Management Update: [00:02:53] GLS said that the demand softness
Laurus Labs Limited Q2 FY23 Earnings Conference Call Insights
https://youtu.be/ZaM0EH45MvA Key highlights from Laurus Labs Limited (LAURUSLABS) Q2 FY23 Earnings Concall Management Update: [00:10:45] LAURUSLABS said that on the R&D front,
Gland Pharma Limited Q2 FY23 Earnings Conference Call Insights
https://youtu.be/4X77Cs34eLo Key highlights from Gland Pharma Limited (GLAND) Q2 FY23 Earnings Concall Management Update: [00:02:23] GLAND said it saw improvement in supplies
Gland Pharma Limited (GLAND) Q2 FY23 Earnings Concall Transcript
Gland Pharma Limited (NSE:GLAND) Q2 FY23 Earnings Concall dated Oct. 26, 2022 Corporate Participants: Sumanta Bajpayee — Vice President, Corporate Finance and Investor Relations
Torrent Pharmaceuticals Ltd Q2 FY23 Earnings Conference Call Insights
Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q2 FY23 Earnings Concall Q&A Highlights: [00:06:41]Damayanti Kerai from HSBC asked about split of India
Jubilant Pharmova reports dip in its net profit by 97% for Q2FY23
Jubilant Pharmova reported total income of INR 1,599.5 crores during the period ended September 30, 2022 as compared to INR 1,657.7 crores
Torrent Pharmaceuticals Limited Q2FY23; Profits down by 1%
Torrent Pharmaceuticals Ltd.‘s Revenues for Q2 FY23 has increased by 7% YoY to ₹ 2,291 crores. Net Profit fell by 1% YoY
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q2 FY23 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Sudhir Menon -- Chief Financial Officer & Executive
SBI LIFE INSURANCE CO LTD (SBILIFE) Q2 FY23 Earnings Concall Transcript
SBI LIFE INSURANCE CO LTD (NSE:SBILIFE) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Mahesh Kumar Sharma -- Managing Director
Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Transcript
Glenmark Life Sciences Limited (NSE:GLS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Soumi Rao -- Head - Corporate Communications
Laurus Labs Limited (LAURUSLABS) Q2 FY23 Earnings Concall Transcript
Laurus Labs Limited (NSE:LAURUSLABS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Satyanarayana Chava -- Chief Executive Officer V.V. Ravi Kumar -- Chief Financial Officer Analysts:
Decoding India’s leading API development company – Dr Reddy’s Laboratories
About Company: Founded in 1984 and headquartered in Hyderabad, India, Dr Reddy’s Laboratories (DRL) is India’s second largest pharma company by global
Syngene International Ltd (SYNGENE) Q2 FY23 Earnings Concall Transcript
Syngene International Ltd (NSE:SYNGENE) Q2 FY23 Earnings Concall dated Oct. 20, 2022 Corporate Participants: Avantika Mishra -- Investor Relations` Jonathan Hunt --
Granules India Ltd (GRANULES) Q2 FY23 Earnings Concall Transcript
Granules India Ltd (NSE:GRANULES) Q2 FY23 Earnings Concall dated Oct. 20, 2022 Corporate participants: Irfan Raeen -- Investor Relation Dr. Krishna Prasad